Connor, Clark & Lunn Investment Management (CC&L)’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-42,687
Closed -$2.03M 1212
2022
Q3
$2.03M Buy
+42,687
New +$2.03M 0.01% 493